June 30 (Reuters) - Aap Implantate AG AAQG.DE :
* FY 2019 SALES GROWTH OF 9% TO EUR 11.7 MILLION
* AAP IMPLANTATE - RESTRUCTURING MEASURES SUCH AS STAFF
REDUCTION
ANNOUNCED IN MARCH WILL LEAD TO ONE-TIME EXPENSES IN CURRENT FY
* MANAGEMENT BOARD EXPECTS A SIGNIFICANTLY LOWER LEVEL OF
SALES
AND EARNINGS FOR FINANCIAL YEAR 2020
* FY 2019 EBITDA IN AMOUNT OF EUR -5.1 MILLION VERSUS EUR
-6.4
MILLION
* 2020 SALES ARE EXPECTED TO BE BETWEEN EUR 8 MILLION AND
EUR 10
MILLION AND EBITDA BETWEEN EUR -6.7 MILLION AND EUR -5.5 MILLION
Source text for Eikon: ID:nEQ5kr441a
Further company coverage: AAQG.DE
((Reuters.Briefs@thomsonreuters.com;))